Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women

A Randomised, Open-label, Single-centre, Single- and Multiple-dose Interventional Study Investigating the Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women

The purpose of this study is to determine the pharmacokinetic (PK) parameters of vortioxetine after single and multiple oral dosing to healthy Chinese men and women.

Inclusion Criteria:

• Healthy young Chinese men or women
• Between 18 and 45 years of age (extremes included)
• BMI between 18.5 and 24 kg/m2 (extremes included)
• Body weight ≥45 kg.

Exclusion Criteria:

• Pregnant or lactating.
• Previously been dosed with vortioxetine
• The subject has taken any investigational medicinal products within 3 months prior to the first dose of IMP (investigational medicinal product)

Other protocol defined inclusion and exclusion criteria may apply